Health
Large-Scale Trial of Ovarian Cancer Screening Fails to Reduce Deaths – DocWire News
A large-scale UK trial of ovarian cancer screening was unable to reduce deaths from the disease, according to a study published in The Lancet. In this
A large-scale UK trial of ovarian cancer screening was unable to reduce deaths from the disease, according to a study published in The Lancet.
In this study, researchers examined more than 200,000 women aged 50-74 who were randomly assigned to one of three groups: no screening, annual screening using an ultrasound scan, and annual multimodal screening involving a blood test followed by an ultrasound scan as a second line test. The population of interest were followed for an average of 16 years.
…
-
Business19 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News18 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business18 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
General19 hours agoRajwinder Singh, on trial for murder of Toyah Cordingley, told undercover officer he saw ‘killers’ and ‘ran’